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The RAG1 endonuclease, together with its cofactor
RAG2, is essential for V(D)J recombination but is a
potent threat to genome stability. The sources of
RAG1 mis-targeting and the mechanisms that have
evolved to suppress it are poorly understood. Here,
we report that RAG1 associates with chromatin at
thousands of active promoters and enhancers in
the genome of developing lymphocytes. The mouse
and human genomes appear to have responded by
reducing the abundance of ‘‘cryptic’’ recombination
signals near RAG1 binding sites. This depletion
operates specifically on the RSS heptamer, whereas
nonamers are enriched at RAG1 binding sites.
Reversing this RAG-driven depletion of cleavage
sites by insertion of strong recombination signals
creates an ectopic hub of RAG-mediated V(D)J
recombination and chromosomal translocations.
Our findings delineate rules governing RAG binding
in the genome, identify areas at risk of RAG-mediated
damage, and highlight the evolutionary struggle to
accommodate programmed DNA damage in devel-
oping lymphocytes.
INTRODUCTION
Vertebrate lymphocytes appear to be unique in their tolerance
for, and dependence on, programmed DNA breakage and rear-
rangement during multiple developmental stages. V(D)J recom-
bination occurs during early B- and T-lymphocyte development,
assembling the immunoglobulin (Ig) and T cell receptor (Tcr)
genes from arrays of V, D, and J gene segments. The diversity
arising from this locus-specific recombination creates the basis
for the immense variation in antigen recognition capacity of the
mature lymphocyte population.The proteins that initiate V(D)J recombination, RAG1 and
RAG2, form an endonuclease with a preferred DNA sub-
strate—the recombination signal sequence (RSS)—that immedi-
ately flanks V, D, and J gene segments. The RSS consists of a
heptamer (consensus 50-CACAGTG) and nonamer (consensus
50-ACAAAAACC) separated by a degenerate spacer of either
12 or 23 base pairs (bp). The heptamer serves as the cleavage
target and the nonamer provides an important binding site for
RAG1 (Schatz and Swanson, 2011). Efficient DNA cleavage
and recombination require synapsis of one 12-RSS and one
23-RSS. Once cleaved, the DNA ends are ligated by non-homol-
ogous end joining (NHEJ) (Rooney et al., 2004), resulting in the
juxtaposition of two coding gene segments and precise joining
of the RSSs.
RAG1 serves as the workhorse for DNA cleavage. It contains a
DDE motif that coordinates divalent metal ions and catalyzes
cleavage, as well as several regions that directly bind to the
RSS (Schatz and Swanson, 2011). RAG2, in contrast, is an
accessory factor that enables RAG1 cleavage activity and en-
hances sequence-specific recognition of the RSS by RAG1.
RAG2 makes limited direct contact with the DNA and does not
contribute directly to enzymatic activity (Swanson, 2004; Zhao
et al., 2009). A C-terminal plant homeodomain (PHD) tethers
RAG2 to tri-methylated histone H3 lysine 4 (H3K4me3) (Liu
et al., 2007; Matthews et al., 2007), a ubiquitous chromatin
marker of active transcription start sites (TSSs). Consequently,
RAG2 localization to chromatin mirrors the deposition of
H3K4me3 (Ji et al., 2010), exhibiting no particular preference
for the Ig or Tcr loci over the thousands of other highly expressed
genes in lymphocytes.
Potential substrates for RAG-mediated cleavage are remark-
ably abundant in vertebrate genomes.Such crypticRSSs (cRSSs)
occur an estimated once per 600 bp (Lewis et al., 1997). This can
be attributed to the sequence variation tolerated at multiple posi-
tions in the heptamer and nonamer, along with the degeneracy of
the spacers. In fact, CA repeats, which mimic the heptamer and
nonamer and exist in thousands of copies in mammalian ge-
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Lewis, 2000; Sakata et al., 2004; Stallings et al., 1991). Lapses in
RAG fidelity involving cRSSs have been shown to cause onco-
genic translocations and interstitial deletions (Gostissa et al.,
2011; Marculescu et al., 2002; Onozawa and Aplan, 2012; Tsai
and Lieber, 2010).
Given that RAG2 occupies a significant proportion of the
active chromatin landscape, and that cRSSs are strewn about
the genome, one might expect that the site-specificity of V(D)J
recombination would be enforced through restriction of RAG1
binding to antigen receptor genes. However, here we show
that RAG1 is not exclusively targeted to the Ig and Tcr genes
but instead colocalizes with RAG2 at thousands of sites. This
begs the question: how are these sites protected from RAG
cleavage through the multiple rounds of V(D)J recombination
required for lymphocyte maturation? Developing B and T cells,
by necessity, perch on the edge of genomic instability, and
even a single instance of off-target cleavage creates broken
DNA ends that can contribute to local rearrangements or long-
range translocations.
We postulated that the deleterious effects of mis-targeted
RAG activity on whole-organism fitness could have applied se-
lective pressure on vertebrate genomes, gradually suppressing
functional cRSSs over evolutionary time. In support of this hy-
pothesis, we show that the sequence environments surrounding
RAG1 binding sites exhibit a reduced probability of containing
cRSSs, particularly heptamer-like motifs, compared to sites in
the genome that are devoid of RAG1 binding. We used genome
editing to experimentally ‘‘reverse’’ the cRSS depletion in vivo,
converting weak cRSS-like sequences into pairs of consensus
RSSs. This created ectopic hot spots for local rearrangement
and long-range translocation, highlighting the danger imposed
by strong cRSSs in the genome. We propose that the selective
pressure exerted by RAG off-target activity has re-shaped the
vertebrate genome, buffering against the obligate genotoxic
stress that occurs during lymphocyte development.
RESULTS
Our previous analysis of the murine Tcra, Tcrb, Igk, and Igh loci
using chromatin immunoprecipitation (ChIP) revealed that the
RAG proteins accumulate in a ‘‘recombination center’’ over the
J and J-proximal D gene segments (Ji et al., 2010). This analysis
left largely unaddressed the questions of if and where RAG1
binds outside of antigen receptor loci. To address these issues,
we performed ChIP sequencing (ChIP-seq) for RAG1 and RAG2
in total thymocytes andCD19+ B-lineage bonemarrow cells from
wild-type (WT) or RAG mutant mice. ‘‘D’’ mice are deficient in
endogenous RAG1, but harbor a bacterial artificial chromosome
(BAC) expressing a RAG1 catalytic mutant (D708A) that retains
its DNA binding properties. Combining ‘‘D’’ with a Tcrb trans-
gene or with a pre-rearranged B1-8i Igh knock-in allele yielded
‘‘Db’’ or ‘‘BD’’ mice, which were used for the analysis of thymo-
cytes (almost exclusively CD4+CD8+ pre-T cells) or B lineage
cells (almost exclusively pre-B cells), respectively (Ji et al.,
2010). We also analyzed RAG1/ and RAG2/ mice bred to
contain the Tcrb transgene or B1-8i Igh allele, as well as core
RAG1 (‘‘cR1’’) mice (expressing the catalytic core of RAG1, aa
384–1008 of 1040 aa) and ‘‘R2DC’’ mice (expressing aa 1–352752 Cell 162, 751–765, August 13, 2015 ª2015 Elsevier Inc.of the 527 aa RAG2 protein) that lacks the PHD (Gigi et al.,
2014; Liang et al., 2002). Both lymphocyte development and
V(D)J recombination occur with reduced efficiencies in cR1
and R2DC mice (Dudley et al., 2003; Liang et al., 2002). Finally,
we analyzed human thymocytes to investigate whether RAG
binding patterns are evolutionarily conserved.
Recombination Centers in High Resolution
Analysis of thymocytes from recombination-incompetent Db
mice identified the Tcra and Tcrb recombination centers as
broad peaks of RAG1, RAG2, and H3K4me3 over the 50 Ja seg-
ments (Figures 1A and 1B, i, iv, and vii), the Db1–Jb1 segments
(Figure S1A), and Db2–Jb2 segments (not shown), consistent
with our previous analysis (Ji et al., 2010). The Tcrd recombina-
tion center was tightly focused over Dd2–Jd1 (Figure 1C). A
similar analysis of B-lineage cells from BD mice confirmed the
location of the Igk (Figure 1D) and Igh (Figure S1B) recombination
centers and identified RAG recruitment hubs in Igl, which
featured strong RAG binding over the Jl3–Jl1 region and
weaker binding at Jl2 and Vl3 (Figure 1E).
InWT thymocytes, which are heterogeneous in developmental
stage and recombination status of their antigen receptor genes,
RAG1, RAG2, and H3K4me3 spread into 30 Ja segments (Fig-
ure 1B, ii, v, viii). This alteration likely reflects the incremental
extension of chromatin accessibility to downstream Ja seg-
ments as recombination progresses (Hawwari and Krangel,
2007) and the resulting cellular heterogeneity in Ja segment us-
age. A similar pattern of RAG bindingwas observed in the human
TCRa/d locus (Figure S1C).
RAG1 occupancy often extended outside of the regions con-
taining the gene segments and their RSSs, spreading along the
domain marked by H3K4me3 (Figures 1D, S1A, and S1B). This
provided an initial indication that RAG1 recruitment could be
dissociated from the RSS, in contrast to the conclusions of our
previous study (Ji et al., 2010). Indeed, as we examined the
remainder of the genome, we found the presence or absence
of RSSs was a poor predictor of RAG1 localization and that
most of the rules governing RAG1 binding applied to both the
antigen receptor loci and the rest of the genome.
RAG1 Binds to Thousands of Sites in the Lymphocyte
Genome
Our previous study identified genome-wide co-localization of
RAG2 and H3K4me3 in thymocytes (Ji et al., 2010). Here, we
used a different a-RAG2 antibody to validate this in mouse thy-
mocytes (Figures 1B, 2A–2C, and S2A; Table S1), mouse pre-
B cells (Figures 1D, 1E, and 2H), and human thymocytes (Figures
S1C and S2C). These datasets confirmed that RAG2 binding
patterns are RAG1-independent (Figures S1D, vi and vii, and
S2A, vi and vii), but require the RAG2 C-terminal region contain-
ing the PHD (Figures S1D, x, and S2A, x). Since RAG2 exhibits no
known catalytic activities, its widespread distribution to active
genes seemed relatively innocuous.
Surprisingly, RAG1 co-localized with a subset of RAG2 and
H3K4me3 peaks (Figures 2A, 2D, and 2F; Table S1), affixing a
potent endonuclease to 3,500 sites in the thymocyte genome.
Similarly, RAG1 occupied3,400 sites inmouse pre-B cells (Fig-
ures 2H and 2I) and 1,800 sites in human thymocytes (Figures
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Figure 1. Recombination Centers of Antigen Receptor Genes
ChIP-seq (reads permillionmapped reads, in raw (unfiltered) form) for RAG1 (blue), RAG2 (green), and H3K4me3 (orange) are shown for selected antigen receptor
genes in mouse lymphocytes. (A) The Tcra/d locus, (B) Tcra recombination center (magnified), and (C) Tcrd recombination center (magnified) are shown for
thymocytes. (D) The Igk recombination center (magnified) and (E) Igl locus are shown for pre-B cells.
See also Figure S1.S2C–S2E), with the lower number in the latter likely reflecting the
weaker ChIP-seq signals obtained. The intensity of RAG1 bind-
ing was, in some cases, comparable to that observed in recom-bination centers (Figures 1B and 2A) and correlated well with the
density of RAG2 and H3K4me3 present (Figures 2E and 2G).
Given the strong correlation between RAG1 binding andCell 162, 751–765, August 13, 2015 ª2015 Elsevier Inc. 753
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Figure 2. RAG1 and RAG2 Bind to Thousands of Sites in the Lymphocyte Genome
(A) ChIP-seq for RAG1, RAG2, and H3K4me3 are shown for a region of chromosome 6 in mouse thymocytes (same color coding as in Figure 1).
(B and C) Overlap (B) and correlation (C) between RAG2 and H3K4me3 peaks.
(legend continued on next page)
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AD
C
B Figure 3. RAG1 Binding Sites Overlap with
TSSs and Accessible Chromatin
(A) RAG1 and H3K4me3 peaks in mouse thymo-
cytes were characterized by their overlap with TSSs
(defined as ±2 kb from an annotated gene start
position), gene bodies, or intergenic regions. Non-
TSS peaks were further categorized as overlapping
with active or poised enhancers.
(B and C) RAG1 RPKM (B) and H3K4me3 RPKM (C)
are shown for each category of RAG1 peak.
(D) Overlap between RAG1, H3K4me3, and
accessible chromatin (defined by ATAC-seq) is
shown for mouse pre-B cells.
See also Figure S3.H3K4me3, it is unsurprising that the majority (81%) of RAG1
peaks overlapped with TSSs (Figure 3A). The remaining TSS-
distal peaks (>2 kb away from a TSS) showed lower levels of
RAG1 binding, reduced H3K4me3 density, and overlap with
active enhancers (H3K4me1+, H3K27Ac+) (Figures 3A–3C). The
reproducibility of peaks (Figure S1E) and extremely weak signals
in our negative controls (RAG1 and RAG2 ChIP-seq in their
respective knock-outs; one exception is noted in Figure S2F)
(Figures 1B and 2A, iii and vi) provided strong support for the ve-
racity of these RAG1 binding sites. Furthermore, we validated
multiple TSS-proximal RAG1 peaks using ChIP-qPCR, a far
less sensitive method than ChIP-seq (Figure S2B).(D and E) Overlap (D) and correlation (E) between RAG1 and H3K4me3 peaks.
(F and G) Overlap (F) and correlation (G) between RAG1 and RAG2 peaks. Boxplots in (D) and (F) show the H
mapped reads), respectively, in sections ‘‘B’’ and ‘‘C’’ of the corresponding Venn diagrams.
(H) ChIP-seq for RAG1, RAG2, and H3K4me3 are shown for a selected region of chromosome 5 in mouse
(I) Venn diagrams show the overlap between RAG1 andH3K4me3, and between RAG1 and RAG2 in pre-B ce
(B) and (D) because one RAG peak can overlap with more than one H3K4me3 peak and vice versa.
See also Figure S2 and Table S1.
Cell 162, 751–76The association of RAG1 with active
TSSs and enhancers suggested that chro-
matin accessibility might be important in
governing RAG1 binding. To explore this,
we compared RAG1 binding sites to areas
of accessible chromatin identified by
assay for transposase-accessible chro-
matin sequencing (ATAC-seq) (Buenrostro
et al., 2013). This revealed that 80% of
RAG1 binding regions in pre-B cells lie
within accessible areas (Figure 3D).
Furthermore, 84%and 86%of RAG1 bind-
ing sites in thymocytes and pre-B cells,
respectively, lie within 1 kb of a CpG island
(Supplemental Experimental Procedures),
an element associated with promoters
and low nucleosome density (Fenouil
et al., 2012). Together, our data suggested
that high levels of H3K4me3 and chromatin
accessibility define a preferred repertoire
of genomic binding sites for RAG1.
RAG1 binding was reduced in magni-
tude and perturbed in thymocytes lackingRAG2 (Figures S1D, S2A, S3A, and S3B). Furthermore, in both
R2DC and cR1 thymocytes, RAG1 binding became less selec-
tive, expanding to thousands of additional sites characterized
by relatively low levels of RAG1 and H3K4me3 (Figures S3C–
S3H). The interpretation of these observations is uncertain
because RAG1 expression is elevated in thymocytes of
these genotypes (Figure S1F). RNA-sequencing (RNA-seq)
and micrococcal nuclease-sequencing (MNase-seq) experi-
ments revealed no clear evidence that widespread RAG
binding influences gene expression or nucleosome positioning
(Figures S3I and S3J; Table S2; Supplemental Experimental
Procedures).3K4me3 and RAG2 RPKM (reads per kb per million
pre-B cells.
lls. The sumof H3K4me3 peaks is not equal between
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Off-Target Recombination by RAG Appears to be the
Exception, Not the Rule
Outside of one indispensable characteristic (the 50 CAC of the
heptamer) and a preference for an AT-rich central nonamer re-
gion (Swanson, 2004), RAG substrate recognition accommo-
dates sequence variation in both the heptamer and nonamer.
As a consequence, the mouse and human genomes are pre-
dicted to contain millions of cryptic RSSs with at least a low level
of function (Lewis et al., 1997; Merelli et al., 2010).
Using our genomic maps of RAG1 binding as a starting point,
we investigated the extent of RAG1-mediated rearrangements in
the genome. The RSS Information Content (RIC) algorithm (Cow-
ell et al., 2002), was used to query the top 100 RAG1 binding
peaks in mouse thymocytes for cryptic 12- and 23-RSS pairs
passing established thresholds and falling within 1 kb of the
peak boundaries. Three examples (Rag1, Cd8a, and Ets2) were
tested for local rearrangements in mouse thymocytes using
PCR assays designed to detect the expected deletional or inver-
sional recombination product (Figures 4A–4C and S4A). Despite
the robust accumulation of RAG1, RAG2, and H3K4me3 near
these cRSSs, recombination events were not detected for any
of the pairs, even after assaying millions of thymocyte genomes
(Supplemental Experimental Procedures).
We used a plasmid substrate to measure the intrinsic recom-
bination potential of the tested cRSSs when paired with a
consensus partner RSS (Figures 4D and 4E). The cRSSs were
tested in competitionwith a known cRSS, which facilitated quan-
titation and comparisons of activity (Agard and Lewis, 2000).
Recombination was assessed by PCR after transfection into
293T cells (together with RAG expression vectors), with activity
expressed relative to that of the internal reference cRSS. The
cRSSs present in the Rag1 and Cd8a loci showed very low
recombination activity in this assay, consistent with their lack
of activity in vivo, while Ets2 contained an active 12-cRSS but
a weak 23-cRSS (Figures 4D and 4E). The two Ets2 cRSSs
showed no detectable recombination activity when paired with
one another in a plasmid recombination assay (Figure S4D),
consistent with their inactivity in vivo.
Prior studies of lymphoma-associated chromosomal rear-
rangements identified a small number of active cRSS pairs,
including those located in the mouse Notch1 and Bcl11b loci
(Sakata et al., 2004; Tsuji et al., 2004). The 50 end of the Notch1
locus features low levels of RAG1 occupancy (ranked 846th
among RAG1 binding sites in thymocytes), along with a pair of
cRSS that span12 kb around the TSS (Figure 4F). Even though
the RIC scores of these two cRSSs fall below those of Rag1,
Cd8a, and Ets2 (Figure S4A), we detected Notch1 deletions at
a frequency of 2.5 3 106 in wild-type thymocytes (Figures
4H and S4B), consistent with prior studies (Tsuji et al., 2004).
The Notch1 deletion junctions showed hallmarks of classical
coding joints (Table S3). Repeated isolation of identical junction
sequences suggested that clones bearing individual deletion
events had expanded in vivo, obscuring the true deletion
frequency.
At Bcl11b (ranked 101st in RAG1 binding density), an 64 kb
deletion takes place between a defined 12-cRSS and one of
several 23-cRSSs that arise within a CA-rich region near the pro-
moter (Figures 4G and S4A). We detected these events in wild-756 Cell 162, 751–765, August 13, 2015 ª2015 Elsevier Inc.type thymocytes at a frequency of 2 3 105 (Figures 4I and
S4C), consistent with prior reports (Sakata et al., 2004). In
contrast to the pauciclonal junctions observed for Notch1 dele-
tions, the coding joints formed at Bcl11b were highly diverse
(Table S3). Analysis of the Bcl11b coding and signal joints iden-
tified multiple 23-cRSSs within the CA-rich region (Table S3),
demonstrating that a CA repeat region can create multiple sub-
strates for off-target recombination.
The intrinsic recombination activity of each Notch1 and
Bcl11b cRSS was assessed in the plasmid recombination assay
(Figures 4D and 4E). The Notch1 cRSSs showed weak activity
while the Bcl11b cRSSs were more active, in line with their
respective recombination activities in vivo. However, when
paired with one another in a plasmid recombination assay, the
two Bcl11b cRSSs showed no detectable activity (Figure S4D),
suggesting that the ability to detect their activity in vivo may
reflect biological selection. Such selection operates on the
Notch1 deletion, which allows for production of a constitutively
active form of the Notch1 protein (Ashworth et al., 2010).
Cryptic Recombination Increases in the Absence of
Ataxia-Telangiectasia Mutated Kinase
The ataxia-telangiectasia mutated kinase (ATM) mediates the
cellular response to DNA double-stranded breaks (DSBs) (Shiloh
and Ziv, 2013). Lymphocytes lacking ATM resolve V(D)J recom-
bination intermediates less proficiently, allowing broken ends to
accumulate and participate in hybrid joint formation (Brede-
meyer et al., 2006) and chromosomal translocations (Helmink
and Sleckman, 2012; Zhang et al., 2012). Notably, Notch1 and
Bcl11b deletion frequencies increased2-fold in Atm/mouse
thymocytes (Figures 4H and 4I). This effect depended more
strongly on ATM than on H2AX and MDC1, two phosphorylation
targets of ATM involved in the DSB repair response. ATM-
dependent apoptosis is unlikely to counteract cRSS-mediated
rearrangements, since p53/ and WT thymocytes showed
similar frequencies of Notch1 and Bcl11b deletions (Figures 4H
and 4I).
To determine if ATM deficiency also sensitized thymocytes
to other rare cryptic recombination events, we tested Atm/
mouse thymocytes for RAG-mediated recombination of the
cRSSs atRag1,Cd8a, and Ets2. No events were detected, again
after screening millions of genomes (Supplemental Experimental
Procedures). Efforts to detect hybrid joint formation at Cd8a and
Ets2 in Atm/ thymocytes were equally unsuccessful (data not
shown). Thus, ATM deficiency did not unmask cRSS recombina-
tion at these three loci.
Cryptic RSSs and Heptamers, but Not Nonamers, Are
Depleted from RAG1 Binding Sites
We hypothesized that the fitness disadvantage conferred by
cRSS-mediated rearrangements had applied selective pressure
during vertebrate evolution against the presence of cRSSs near
sites of RAG1 recruitment. We first asked whether the regions
encompassed by RAG1 binding peaks (outside of antigen recep-
tor genes) had a lower incidence of cRSSs than similarly sized
but randomly chosen regions of the genome. Indeed, RAG1+ re-
gions from mouse pre-B cells and thymocytes exhibited a 25%–
48% lower density of 12- and 23-cRSSs than random segments
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Figure 4. Off-Target Cleavage by RAG Is Rare and Restricted by ATM
RAG1, RAG2, and H3K4me3 ChIP-seq data are shown for (A) Rag1, (B) Cd8a, (C) Ets2, (F) Notch1, and (G) Bcl11b in WT mouse thymocytes. The 12-cRSSs and
23-cRSSs are indicated by open and filled triangles, respectively. Small arrows represent PCR primers used to assay for RAG-dependent deletions or inversions,
and thick lines represent gene bodies. (D and E) The intrinsic recombination activity of selected cRSSs was assayed using a plasmid substrate, diagrammed
above each panel. Arrows, PCR primers for recombination assay; position 1, reference cRSS (either the Lmo2 12-cRSS or a modified Ttg1 23-cRSS,
open triangle); position 2, test 12- or 23-cRSS (red open triangle); position 3, appropriate consensus partner RSS (filled black triangle). Recombination activity
(mean + SEM) of each test cRSS is shown relative to that of the reference cRSS. RAG-mediated deletions at the mouse (H) Notch1 and (I) Bcl11b loci were
detected using a nested PCR assay. The frequency of deletions (mean ± SEM) is shown for WT, Rag1/, Atm/, H2ax/,Mdc1/, and P53/ thymocytes.
Each point represents data generated from one mouse. Unpaired t test, *p% 0.05, ***p% 0.001. ns, not significant.
See also Figure S4 and Table S3.
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of the genome (Figure 5A). This demonstrates that co-binding
of RAG1 andRAG2 occurs in regions of the genome that are rela-
tively depleted of potential cleavage sites.
Is this driven by the presence of RAG, or is it simply a side
effect of the types of genomic regions bound by RAG1? For
instance, TSSs and their flanking promoters might have
a reduced incidence of cRSSs simply because of functional
constraints inherent in these regions. To control for this, we
compared the density of cRSSs surrounding RAG1+ and
RAG1– TSSs, which revealed that the area flanking TSSs as a
whole did indeed have a lower incidence of cRSSs than TSS-
distal regions (Figure 5B). Importantly, however, cRSS density
was lower in RAG1+ TSSs (n = 4,087; combined list from thymo-
cytes and pre-B cells) compared to RAG1– TSSs (n = 16,412), a
phenomenon that also extended to CA density (Figure 5B).
Hence, RAG1+ TSSs show a substantial depletion of both
cRSS and CA density beyond that of other TSSs.
This analysis did not take into account certain features of
RAG1+ TSSs, namely elevated CpG and GC content (Figures
S5A and S5B). Such differences in base composition between
the RAG1+ and RAG1 groups could contribute to the differ-
ences observed. To control for this, we created lists of genomic
regions in non-lymphoid cell types that mimicked the RAG1+ re-
gions from pre-B cells and thymocytes in terms of overlap with
TSSs (Figure S5C), H3K4me3 levels (Figure S5D), and CpG
(Figure S5E) and GC (Figure S5F) content (Supplemental Exper-
imental Procedures). Our hypothesis predicted that cRSS con-
centration should be lower in RAG1+ regions in lymphocytes
than in closely matched regions from other tissues that do not
express RAG. Strikingly, the densities of both 12-cRSSs (Fig-
ure 5C) and 23-cRSSs (Figure 5D) were lower in the RAG1+
regions of thymocytes and pre-B cells than in matched control
regions of six different non-lymphoid cell types. The differences
were small but highly significant, particularly for the 23-cRSS
(Table S4).
Given the different functions served by the heptamer (site of
cleavage) and nonamer (DNA binding), we hypothesized that
the two RSS components were subject to different degrees of
selective pressure. We repeated the above analysis but focused
on ‘‘high scoring’’ heptamers and nonamers (defined by position
weight matrix; Supplemental Experimental Procedures). This re-
vealed a highly significant reduction in the probability of finding
heptamers at RAG1+ regions as compared to control regions in
both pre-B cells and thymocytes (Figure 5E), and remarkably,Figure 5. Sites of RAG1 Binding Are Preferentially Depleted of Cryptic
(A) The density of 12-cRSSs and 23-cRSSs was calculated for regions of the geno
cells (bottom) compared to randomly assigned (Shuffle, gray) genomic regions (1
(B) The densities of 12-cRSSs, 23-cRSSs, and CA dinucleotides were plotted acr
include those bound by RAG1 in either mouse thymocytes or pre-B cells.
(C) The 12-cRSS content in RAG1+ H3K4me3+ regions in mouse thymocytes (lef
H3K4me3+ regions of non-lymphoid tissues. Cumulative distribution plots show
12-cRSSs. A shift to the left indicates depletion; a shift to the right indicates enri
(D–F) Similar analyses were done for (D) 23-cRSSs, (E) high scoring heptamers,
(G and H) Densities of high scoring heptamers and nonamers in RAG1+ and RAG1
thymocytes.
(I) RAG1 and H3K4me3 ChIP-qPCR (mean + SEM, n = 3) in STI-571-treated Rag1
RAG1, or RAG1 NBD mutant (NBDm).
See also Figure S5 and Table S4.the opposite for nonamers, which were enriched in RAG1+ re-
gions (Figure 5F; Table S4). These phenomena were also evident
in a TSS-centered analysis, where heptamers were less abun-
dant in RAG1+ versus RAG1 regions, while nonamers were
more abundant (Figure 5G). Similar results were obtained for
RAG1+ versus RAG1 TSSs in human thymus (Figure 5H). This
argues for selection during vertebrate evolution focused on
depleting the heptamer, consistent with its role in directing
DNA cleavage by RAG.
Nonamer enrichment at RAG1+ regions raised the possibility
that a portion of RAG1 binding is mediated by direct RAG1-non-
amer interactions. To test this, we reconstituted a Rag1/ Abel-
son kinase-transformed pre-B cell line (v-abl) with WT RAG1 or a
RAG1mutant (NBDm) in which DNA contact residues in the non-
amer binding domain (NBD) were altered (R391A, R393A,
R407A). We found that binding of the NBDm protein was invari-
ably decreased (though not ablated) relative to WT RAG1 (Fig-
ure 5I). This difference was most prominent at Jk5, as expected
(Ji et al., 2010). Importantly, decreased binding was observed at
six different promoter regions (Figure 5I), including three genes
with no high-scoring nonamers within 1 kb of the site assayed
for binding. Hence, the NBD is important for the association of
RAG1 with chromatin and its contribution likely derives from
both sequence-specific and sequence-nonspecific interactions
with DNA.
RSSs Inserted into the Genome Create Ectopic
Recombination Hot Spots
Our analyses thus far suggested that substrate availability is an
important functional difference between a RAG complex occu-
pying an antigen receptor gene and an ‘‘ectopic’’ RAG complex
occupying a non-antigen receptor gene. This predicted that the
latter can be converted into a recombination hot spot simply by
the presence of a strong RSS pair. To test this, we introduced
consensus 12- and 23-RSS pairs into specific sites of the
lymphocyte genome (Figure 6A) in a v-abl pre-B cell line, which
upregulates RAG and Igk recombination in response to the v-
abl kinase inhibitor STI-571. A site-specific transcription acti-
vator-like effector nuclease (TALEN) and a targeting construct
containing point mutations in its 50 homology arm that converted
weak RSS-like motifs into consensus RSSs (Figure 6A) were
used to introduce RSSs into a target locus while minimizing addi-
tional sequence alterations (Figure S6A). Depending on the re-
gion of crossover, the modified allele harbored either a pair ofRSSs
me containing a RAG1 binding peak (blue) in mouse thymocytes (top) or pre-B
0,000 shuffles ± SD).
oss a 10 kb region centered on the TSS in mouse lymphocytes. RAG1+ regions
t) and pre-B cells (right) was compared to the 12-cRSS content in comparable
the fraction of regions that contain more than a threshold number (x axis) of
chment.
and (F) high scoring nonamers.
 regions are plotted relative to TSSs for (G) mouse lymphocytes and (H) human
/ v-abl cells reconstituted with a retrovirus expressing no RAG1 (empty), WT
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Figure 6. Insertion of RSSs into the Genome Results in Ectopic V(D)J Recombination
(A) Strategy for targeted introduction of RSSs into the genome. Diagrammed are the target locus (TALEN cleavage site, red arrow) and targeting construct (blue
triangles, LoxP sites; Bsr, Blasticidin resistance gene; T2A, self-cleaving peptide; TK, thymidine kinase; black arrows, PCR primers to detect recombination; open
and filled triangles, consensus 12 and 23 RSSs, respectively). Depending on the region of crossover in the 50 homology arm, indicated by the dashed blue and
orange lines, homologous recombination results in either 12/23 or 23-RSSki, respectively.
(B–G) RAG1 binding patterns at the mouse (B) Cd79b locus and (D) Aicda E1 enhancer are shown in v-abl-transformed pre-B cells treated with STI-571 for 48 hr.
RAG1, RAG2, and H3K4me3 ChIP-seq data are also shown for pre-B cells from BD mice. The RSSki alleles are diagrammed at the bottom. PCR was used to
assay for recombination between the knocked-in RSSs in the (C) Cd79b locus and (E) Aidca E1 enhancer pre- and post-treatment with STI-571. The assay is
specific to the RSSki allele, and amplifies a product from both the un-recombined (upper band) and recombined (lower band) loci. Two clones are shown for
each RSSki cell line, along with the parental v-abl cell line (WT), where the knock-in allele is not amplified by PCR. Histograms show the percent recombination
(legend continued on next page)
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12-RSS and 23-RSS (designated as ‘‘12/23’’), or a single 23-RSS
(designated as ‘‘23’’) (Figure 6A).
We first knocked-in RSSs atCd79b (ranked 73rd in RAG1 bind-
ing density in pre-B cells), which features substantial RAG1 and
RAG2 recruitment in both v-abl cell lines and primary pre-B cells
(Figure 6B). Upon treatment with STI-571, the Cd79b-12/23 cell
lines showed clear recombination activity, whereas the Cd79b-
23 cell lines remained inert (Figure 6C). The deletion junctions
showed hallmarks of classical V(D)J recombination (Table S5).
ChIP experiments confirmed RAG1 recruitment to the 12/23-
modified locus (Figure S6B).
We then examined whether a site normally devoid of RAG
binding (the E1 enhancer of Aicda) was also susceptible to off-
target RAG1 activity. Since Aicda is not significantly expressed
at the pre-B cell stage, neither the E1 enhancer nor the gene
showed significant RAG recruitment or H3K4me3 deposition in
v-abl cell lines or primary pre-B cells (Figure 6D). Paired RSSs
placed in the E1 enhancer recombined detectably, albeit at lower
levels than at Cd79b, while single 23-RSSs were again inactive
(Figures 6E and S6B; Table S5; note that the E1-12/23-1 line
was modified on both E1 alleles). Though recruitment of RAG1
was not as robust at the E1-12/23 locus compared to the
Cd79b-12/23 locus (Figure S6B), the presence of recombination
events at E1 confirmed that even low levels of ectopic RAG
recruitment can prove biologically functional. ATAC-seq re-
vealed a peak of accessibility over E1 in pre-B cells (Figure S6C),
suggesting that it is poised for activity in pre-B cells and cell
lines, consistent with the finding that Aicda expression is cyto-
kine-inducible in v-abl cell lines (Kumar et al., 2013). Together,
these results support the catalytic competence of RAG com-
plexes assembled throughout the genome and indicate that
even relatively quiescent areas of the genome are not intrinsically
protected from RAG activity.
The observation of increased recombination between Notch1
and Bcl11b cRSSs in the context of ATM deficiency led us to ask
if ATM inhibition in the RSSki cell lines would have a similar effect
on the knocked-in RSSs. This was indeed the case, as treatment
with an ATM kinase inhibitor (ATMi) reproducibly increased
recombination of the 12/23 RSSki insertions at the Cd79b and
E1 loci (Figures 6F and 6G). Hence, ATM can regulate recombi-
nation of both cryptic and strong RSSs, perhaps through a feed-
back inhibition mechanism (Steinel et al., 2013).
Breaks at Inserted RSSs Undergo Chromosomal
Translocations
Since RAG-dependent breaks in the antigen receptor genes are
known to participate in chromosomal translocations (Gostissa
et al., 2011), we tested the Cd79b and E1 RSSki for translocation
activity. In v-abl cells, RAG-induced breaks at Igk provide an
abundant source of potential translocation partners, and ATMi
strongly sensitizes the cells to RAG-mediated translocations
(Zhang et al., 2012). We readily detected translocations between
Jk gene segments and the RSSki in the Cd79b-12/23 and E1-12/(mean + SEM, n = 3) in each cell line after STI-571 treatment, as determined by a s
ATM inhibitor [black bars] or DMSO [white bars] in combination with STI-571) on
lines. Two subclones (designated ‘‘A’’ and ‘‘B’’) are shown for each of the 12/23-
See also Figure S6 and Table S5.23 cell lines (Figures 7A and 7B). Detection of translocations de-
pended on both STI-571 and ATMi, as expected (Zhang et al.,
2012), and an isolated consensus 23-RSS was inactive for trans-
location (Figure 7B). Translocations between two coding ends,
aswell as those involving anRSSki coding end and the Jk5 signal
end (although, curiously, not the Jk1 signal end), were readily de-
tected and featured imprecise joints with nucleotide additions
and deletions (Figure 7B; Table S6). Translocations involving
the RSSki signal ends (to a Jk coding or signal end) were almost
never detected, which might reflect the design of the RSSki loci
(Supplemental Experimental Procedures).
We also examined whether RSSki breaks could translocate to
RAG-independent, CRISPR/Cas9-generated DSBs in the Hprt
locus. In a Cd79b 12/23-RSSki cell line, this resulted in clear
STI-571/ATMi-dependent RSSki–Hprt translocations with nucle-
otide additions and deletions at the junctions (Figure 7B, ix; Table
S6). We were unable to detect such translocations for the E1 12/
23 RSSki, presumably due to the lower frequency of RSSki
breaks. Together, our data demonstrate unambiguously that a
strong 12/23 RSS pair can create an ectopic hub of recombina-
tion and translocation activity, whereas an isolated RSS, even in
an actively transcribed region, is far less dangerous.
The above results were confirmed by RSSki into the Cd79b lo-
cus in an Atm/ v-abl cell line, revealing robust recombination
and translocation activity for the 12/23 RSSki, while single 23
RSSki alleles were inert (Figures S7A and S7B). To determine
whether such an assay would allow detection of recombination
between cryptic RSSs, the Notch1 or the Bcl11b cRSS pairs
were knocked into the Cd79b or Aicda E1 loci in the Atm/
v-abl cell line. Despite normal levels of RAG protein expression
(not shown), none of these lines yielded detectable recombina-
tion after STI-571 induction (Figure S7C). These findings empha-
size the low recombination potential associated with cRSSs
whose activity remains detectable in vivo.
DISCUSSION
The prior, limited analysis of RAG1 binding at non-antigen re-
ceptor genes was consistent with the model that RAG1 associ-
ation with active chromatin was restricted to regions containing
strong RSSs (Ji et al., 2010). This provided an appealing mech-
anism by which to limit the genotoxic threat of RAG. Our data,
however, reveal that this model is not correct and that antigen
receptor genes are not exceptional in their ability to recruit
RAG1. This fundamentally alters our understanding of the threat
to the genome constituted by RAG and raises questions
regarding the evolutionary response to such widespread
RAG1/RAG2 binding. Our study begins to answer these ques-
tions by characterizing how the genome has adapted to the
threat of RAG and the consequences of reversing this adapta-
tion. Our data also provide an important resource for the anal-
ysis and explanation of patterns of genome instability in
lymphoid malignancies.emiquantitative PCR assay. The effects of ATM inhibition (treatment with either
recombination are shown for the (F) Cd79b and (G) Aicda E1 12/23-RSSki cell
RSSki cell lines.
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Figure 7. RAG-Dependent Breaks at Knocked-In RSSs Undergo Long-Range Chromosome Rearrangements
(A) Three loci were tested for translocations (left to right): the RSSki, Igk, and Hprt (targeted for cleavage by CRISPR/Cas9). Purple, 12RSS coding end; orange,
23RSS coding end; green triangle, Jk1 23RSS; green rectangle, Jk1 gene segment (coding end); blue triangle, Jk5 23RSS; blue rectangle, Jk5 gene segment
(coding end); red arrow, CRISPR/Cas9 cleavage site.
(B) RSSki lines were tested for translocation activity using PCR assays to detect junctions between RSSki DSBs and RAG-dependent DSBs originating from Igk
(i–viii) or RAG-independent DSBs generated atHprt (ix). The outcome of each translocation is diagrammed. 12/23-RSSki (12/23), 23-RSSki (23), andWT cell lines
were assayed with or without treatment with STI-571 (STI) and an ATM inhibitor (ATMi). Translocation products were amplified in at least two independent PCR
experiments. To illustrate translocations between the CD79b RSSki and Hprt (ix), a set of 24 PCR reactions are shown for either wild-type (WT) cells or a Cd79b
12/23-RSSki cell line.
See also Figure S7 and Table S6.Regulation of RAG Recruitment
Our data identify a set of rules that govern the steady state asso-
ciation of RAG1 and RAG2 with chromatin. For RAG2, binding is
independent of RAG1, correlates tightly with H3K4me3, and ap-
pears to be strongly dependent on the RAG2 C-terminal region,
in which the critical domain is almost certainly the PHD.
For RAG1, chromatin accessibility appears to be an important
factor, as demonstrated by strong correlations between RAG1
binding and active promoters and enhancers, H3K4me3,
ATAC-seq, and CpG islands. Open chromatin allows for access
to DNA, and RAG1 has substantial non-specific DNA binding ac-
tivity (Schatz and Swanson, 2011; Zhao et al., 2009). Our finding
that mutation of the NBD reduced RAG1 binding even at regions
lacking strong nonamers argues that non-specific DNA binding
accounts for a substantial portion of the RAG1 binding pattern
and is consistent with structural analysis showing sequence-762 Cell 162, 751–765, August 13, 2015 ª2015 Elsevier Inc.non-specific interactions between the NBD and DNA (Yin
et al., 2009). However, sequence-specific interactions between
RAG1 and the nonamer might also enhance the association of
RAG1 with chromatin, as suggested by our finding that non-
amers are somewhat enriched in the vicinity of RAG1 binding re-
gions. This is consistent with in vivo and biochemical studies
demonstrating specific RAG1-nonamer interactions in the
absence of a heptamer (Swanson, 2004). In addition, the pertur-
bations in RAG1 binding observed when RAG2 is absent or
truncated suggest that the RAG1-RAG2 interaction is also a
significant factor in localizing RAG1 to active chromatin. This
agrees with a recent modeling analysis that predicted that the
RAG complex should localize efficiently to chromatin rich in
H3K4me3 (Askary et al., 2014). Finally, given the ability of
RAG1 to bind and ubiquitinate histone H3 (Deng et al., 2015; Gra-
zini et al., 2010; Jones et al., 2011), it is plausible that direct
RAG1-histone interactions contribute to the observed RAG1
binding pattern.
Our analyses provide a cumulative population description and
it is unknown to what extent individual lymphocytes reflect the
population averages described by ChIP-seq. We also note that
DNA looping between bona fide protein binding sites and distal
elements might explain a portion of the weak, TSS-distal RAG1
binding peaks detected.
While we were unable to identify a function for RAG binding in
regulating gene expression, it is noteworthy that the catalytic
function of RAG is required for the proper development of a sub-
set of natural killer cells and perhaps other non-B/non-T hemato-
poietic lineages as well (Karo et al., 2014). This implies the
involvement of RAG-mediated DNA breaks, and while the sites
of such putative cleavage events are unknown, it is appealing
to think that colocalization of RAG1 and RAG2 to open transcrip-
tional regulatory regions might be relevant.
StrongEctopic RSSs in theGenomeCreate Hot Spots for
Genomic Instability
Robust recombination and translocation activity of the Cd79b
RSSki illustrate the dangers of RSS availability in a pre-existing
region of RAG1 recruitment. This is consistent with results ob-
tained using a Tcrb minilocus inserted into the Myc first intron,
which recombined (Ranganath et al., 2008) and activated the
translocation potential of formerly inert cRSSs in its vicinity (Tep-
suporn et al., 2014). This insertion, however, differed from ours in
its inclusion of antigen receptor gene segments and endogenous
RSSs, one of which contained a TATA box and a cFos binding
site that recruits RAG (Wang et al., 2008). Even the Aicda E1
enhancer, which is normally devoid of RAG binding, transformed
into a recombination and translocation hot spot upon the intro-
duction of paired RSSs. This indicates that de novo sequence-
driven RAG recruitment is no less dangerous than the presence
of RSSs in a pre-existing RAG binding site. In contrast, a single
RSS did not produce detectable levels of local or long-range re-
arrangement, arguing that neither uncoupled (i.e., single RSS)
cleavage nor inter-chromosomal recombination are major con-
tributors to genomic instability, at least in this assay system.
Thus, the genome appears to derive substantial protection
from the requirement for simultaneous engagement of two
RSS substrates for RAG-mediated DSB formation.
Preventing Off-Target Recombination
Multiple mechanisms are likely to protect the lymphocyte
genome in the face of widespread RAG binding. The first is the
ability of inaccessible chromatin to prevent recombination of
even strong RSSs. This is amply illustrated by the inactivity of
Tcr loci in developing B cells, of Ig loci in developing T cells,
and of all antigen receptor loci in fibroblasts expressing RAG
(Cobb et al., 2006). In such instances, not only is RAG likely to
have difficulty gaining access to RSSs, but the dearth of
H3K4me3 would be predicted to significantly hamper stable
RAG recruitment (Askary et al., 2014).
The second mechanism, identified here, is to restrict the avail-
ability of RSS substrates in the genome. We provide evidence
consistent with selection against cRSSs and heptamer se-
quences near sites of RAG1 binding, and given our results withthe Aicda E1 RSSki, it is plausible that such selection extends
to other areas of the genome as well. The extent to which an in-
dividual cRSS represents a threat to genome integrity, and thus
might be selected against, is likely to depend not only on the
linear distance in the genome to a compatible partner cRSS,
but also on higher order chromatin architecture and dynamics,
which will determine the potential for two sites to interact and
support RAG-mediated cleavage (Lucas et al., 2014). Our detec-
tion of cRSS-mediated recombination was restricted to Notch1
and Bcl11b, where rare deletion events are detected by virtue
of their oncogenic potential (Onozawa and Aplan, 2012). This
theme extends to human B cell acute lymphoblastic leukemias
harboring an ETV6-RUNX1 translocation, which express RAG
and contain a high incidence of recurrent interstitial deletions.
Strikingly, the deletion breakpoints are enriched at active pro-
moters and correlate strongly with heptamer motifs without a
discernable nonamer (Papaemmanuil et al., 2014). This provides
a biological rationale for our observation that evolutionary selec-
tion has operated primarily on the heptamer.
Strong cRSSs (with RIC scores comparable to those of anti-
gen receptor gene RSSs) are relatively rare in the mouse
genome, and it is even more rare to find a strong 12-cRSS in
close proximity to a strong 23-cRSS (Table S4). This likely re-
flects the stringent requirements for such sequences, which
must match the RSS consensus at many heptamer and nonamer
positions. The principal danger to genome stability in developing
lymphocytes probably derives from weak cRSS sequences,
consistent with our finding of a relative depletion of cRSS and
heptamers near RAG1 binding sites. Notably, modeling predicts
that RAGwill dissociate from non-specific DNA sequences more
rapidly than it can introduce nicks (Askary et al., 2014), and such
a mechanism might help suppress genome instability at the
many heptamers that remain in open regions of the genome.
The ATMkinase contributes to a thirdmechanism that restricts
cRSS-mediated recombination, as illustrated by the increase in
Notch1 and Bcl11b deletions in Atm/ versus WT thymocytes.
Recent studies support a feedback inhibition model in which
RAG-mediated DNA breaks signal through ATM to temporarily
downregulate further RAG-mediated DNA cleavage, helping to
protect the genome and enforce allelic exclusion (Hewitt et al.,
2009; Steinel et al., 2013). Notably, neither MDC1 nor H2AX
were required for feedback inhibition (Steinel et al., 2013),
consistent with our findings (Figure 4H, I). This model can also
explain the increase we observe in recombination at the RSSki
alleles following treatment with ATMi, since the inhibitor would
prevent feedback inhibition arising from breaks at Igk.
Evolutionary Adaptation to RAG
The arrival of RAG1 and RAG2, perhaps as components of a
transposable element (Thompson, 1995), and their adaptation
into the recombinase underlying adaptive immunity, presented
a significant evolutionary challenge to vertebrate genome integ-
rity. One possible response could have been too tightly restrict
RAG binding to antigen receptor genes, but this might be inher-
ently difficult to accomplish for DNA binding proteins, as illus-
trated by the promiscuous binding of transcription factors at a
multitude of sites of uncertain or no functional relevance (Biggin,
2011). Instead, we propose that an evolutionary responseCell 162, 751–765, August 13, 2015 ª2015 Elsevier Inc. 763
unfolded through gradual selection for mutations that deacti-
vated dangerous ectopic cRSSs, although it is clear that this pur-
ifying process is not complete (Papaemmanuil et al., 2014).
EXPERIMENTAL PROCEDURES
ChIP and ChIP-Seq
ChIP experiments (assayed either by qPCR or sequencing) were performed as
described previously (Ji et al., 2010) using custom monoclonal rabbit anti-
bodies for RAG1 (mAb 23) and RAG2 (mAb 39) (Coster et al., 2012) or a poly-
clonal rabbit antibody for H3K4me3 (Millipore, 07-475). Taqman qPCR primer
and probe sequences can be found in Ji et al. (2010) or in Table S7. ChIP-qPCR
signals were expressed as IP/input minus IgG background3 1,000. For ChIP-
seq, libraries were prepared and sequenced following Illumina protocols.
Sequence tags were aligned to the mouse (GRCm38p2/mm10) or human
(GRCh37/hg19) genomes using Bowtie (version 0.12.7). Peak calling was per-
formed with MACS 1.4.2. See the Supplemental Experimental Procedures for
details on data analysis.
Cell Lines
v-abl-transformed pre-B cell lines—either wild-type (A70.2) (Bredemeyer et al.,
2006) or Atm/ containing an I-SceI substrate integrated in chr18 (Zhang
et al., 2012)—were treated with 3 mM STI-571 for 24 or 48 hr. RSSki v-abl
cell lines were created using TALEN expression plasmids targeting Cd79b or
Aicda E1 enhancer (Kieffer-Kwon et al., 2013). The region 50 of the TALEN
cleavage site was scanned for pre-existing heptamer- and nonamer-like se-
quences, and mutations were designed to convert these RSS-like sequences
into consensus or cryptic RSSs, along with 10 bp of coding flank. A 50 semi-ho-
mology arm bearing the desired point mutations (synthesized by Blue Heron
Biotechnology) and a 30 homology arm were cloned into a targeting construct
containing a floxed Blasticidin-T2a-TK selection cassette. The TALEN expres-
sion vectors and the targeting construct were transfected into v-abl cells by
Amaxa nucleofection. Blasticidin-resistant single cell clones were isolated
and transfected with a Cre expression plasmid to allow for deletion of the se-
lection cassette. Ganciclovir-resistant single cell subclones were isolated. For
descriptions of cell line genotyping, see the Supplemental Experimental
Procedures.
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